KAT2A and leukemia: Alternatively, the lack of association could reflect the fact that our subset of acetylation targets captures absolute, but not relative losses of promoter H3K9ac upon Kat2a KO, as a result of the necessarily limited replication of ChIP analysis of primary leukemia cells.